Interview: Chloe Deutscher: Director of Business Development: PsyGen

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Latest News

FLUENT Shareholders Approve All-Stock Acquisition by Vireo

HCN News Team2026-07-29T03:44:07-08:00July 29th, 2026|

TORONTO – FLUENT Corp. reported that holders of its common and proportionate voting shares approved the special resolution for an all-stock plan of arrangement with Vireo Growth Inc. at the annual general and special meeting ...

IRS Pushes Back on Cannabis Tax Refund Claims as the 280E Battle Enters a New Era

HCN News Team2026-07-20T15:26:26-08:00July 20th, 2026|

WASHINGTON, D.C.-The Cannabis industry's long-running battle with Section 280E has entered a pivotal new phase. For years, one of the greatest financial challenges facing state-licensed Cannabis businesses has not been competition or regulation—it has been ...

Organigram Highlights Early Sanity Results While Holding Canadian Market Lead

HCN News Team2026-07-20T07:21:11-08:00July 20th, 2026|

TORONTO – Three months after closing its largest international acquisition to date, Organigram Global Inc. has delivered the first combined business update covering Sanity Group's early performance alongside the company's ongoing Canadian market position. The ...